Information on the following pages is cited from the Medicare, Medicaid and commercial payers within the individual state and reflects the most current coverage, coding and payment information specific to the particular payer. Allos Therapeutics has no responsibility for the published policies and/or the information contained therein. This information may not be consistent with the current FOLOTYN® (pralatrexate injection) prescribing information and is not intended as an endorsement and makes no representations regarding any usage which is inconsistent with the FDA-approved prescribing information. This information may not be consistent with the current FOLOTYN® (pralatrexate injection) prescribing information and is not intended as an endorsement. Allos Therapeutics makes no representation about, nor recommends the use of FOLOTYN® (pralatrexate injection) which is inconsistent with the FDA-approved prescribing information.